Low-dose aspirin or other nonsteroidal anti-inflammatory drug use and prostate cancer risk: a nationwide study
暂无分享,去创建一个
Jesper Hallas | Christian Dehlendorff | Henrik Toft Sørensen | Michael Borre | A. Tjønneland | H. Sørensen | J. Hallas | S. Friis | M. Borre | K. Brasso | S. Larsen | C. Dehlendorff | Anne Tjønneland | Søren Friis | Charlotte Skriver | Klaus Brasso | Signe Benzon Larsen | Charlotte Skriver
[1] M. Levi,et al. Risk of prostate cancer in low‐dose aspirin users: A retrospective cohort study , 2016, International journal of cancer.
[2] Evelyn Whitlock,et al. Aspirin for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: A Decision Analysis for the U.S. Preventive Services Task Force , 2016, Annals of Internal Medicine.
[3] W. Willett,et al. Population-wide Impact of Long-term Use of Aspirin and the Risk for Cancer. , 2016, JAMA oncology.
[4] Yin Cao,et al. Aspirin and colorectal cancer: the promise of precision chemoprevention , 2016, Nature Reviews Cancer.
[5] R. Erichsen,et al. Low-Dose Aspirin or Nonsteroidal Anti-inflammatory Drug Use and Colorectal Cancer Risk , 2015, Annals of Internal Medicine.
[6] H. Grönberg,et al. The risk of prostate cancer for men on aspirin, statin or antidiabetic medications. , 2015, European journal of cancer.
[7] C. Mathers,et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.
[8] N. Cook,et al. Estimates of benefits and harms of prophylactic use of aspirin in the general population , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.
[9] G. Andriole,et al. Aspirin, NSAIDs, and Risk of Prostate Cancer: Results from the REDUCE Study , 2014, Clinical Cancer Research.
[10] Xiangyi Zheng,et al. Meta-analysis of nonsteroidal anti-inflammatory drug intake and prostate cancer risk , 2014, World Journal of Surgical Oncology.
[11] Timothy J Wilt,et al. Prevention and early detection of prostate cancer. , 2014, The Lancet. Oncology.
[12] T. Tammela,et al. Prostate cancer risk and nonsteroidal antiinflammatory drug use in the Finnish prostate cancer screening trial , 2014, British Journal of Cancer.
[13] Henrik Toft Sørensen,et al. The Danish Civil Registration System as a tool in epidemiology , 2014, European Journal of Epidemiology.
[14] J. Hallas,et al. Potential of prescription registries to capture individual-level use of aspirin and other nonsteroidal anti-inflammatory drugs in Denmark: trends in utilization 1999–2012 , 2014, Clinical epidemiology.
[15] Junhua Zheng,et al. Aspirin use and the risk of prostate cancer: a meta-analysis of 24 epidemiologic studies , 2014, International Urology and Nephrology.
[16] Shan Li,et al. Effect of aspirin and other non-steroidal anti-inflammatory drugs on prostate cancer incidence and mortality: a systematic review and meta-analysis , 2014, BMC Medicine.
[17] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[18] Lau Caspar Thygesen,et al. When the entire population is the sample: strengths and limitations in register-based epidemiology , 2014, European Journal of Epidemiology.
[19] R. Day,et al. Non-steroidal anti-inflammatory drugs (NSAIDs) , 2013, BMJ.
[20] A. Tjønneland,et al. Prostate cancer in Denmark 1978–2009 — trends in incidence and mortality , 2013, Acta oncologica.
[21] Q. Ding,et al. Diabetes mellitus and prostate cancer risk of different grade or stage: a systematic review and meta-analysis. , 2013, Diabetes research and clinical practice.
[22] T. Tammela,et al. Use of aspirin, but not other non-steroidal anti-inflammatory drugs is associated with decreased prostate cancer risk at the population level. , 2013, European journal of cancer.
[23] S. Friis,et al. Completeness of prostate cancer staging in the Danish Cancer Registry, 2004–2009 , 2012, Clinical epidemiology.
[24] P. Rothwell,et al. Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials. , 2012, The Lancet. Oncology.
[25] M. Thun,et al. The role of aspirin in cancer prevention , 2012, Nature Reviews Clinical Oncology.
[26] S. Gallus,et al. Aspirin and urologic cancer risk: an update , 2012, Nature Reviews Urology.
[27] C. Pedersen,et al. The Danish Civil Registration System , 2011, Scandinavian journal of public health.
[28] L. Thygesen,et al. Introduction to Danish (nationwide) registers on health and social issues: Structure, access, legislation, and archiving , 2011, Scandinavian journal of public health.
[29] B. Bjerregaard,et al. The Danish Pathology Register , 2011, Scandinavian journal of public health.
[30] Marianne Lundkjær Gjerstorff,et al. The Danish Cancer Registry , 2011, Scandinavian journal of public health.
[31] Mikkel Baadsgaard,et al. Danish registers on personal income and transfer payments , 2011, Scandinavian journal of public health.
[32] Elsebeth Lynge,et al. The Danish National Patient Register , 2011, Scandinavian journal of public health.
[33] J. Hallas,et al. The Danish National Prescription Registry , 2011, Scandinavian journal of public health.
[34] Vibeke Jensen,et al. Danish education registers , 2011, Scandinavian journal of public health.
[35] Stacey A. Kenfield,et al. Long‐term aspirin use and the risk of total, high‐grade, regionally advanced and lethal prostate cancer in a prospective cohort of health professionals, 1988–2006 , 2011, International journal of cancer.
[36] F. Hamdy,et al. Associations of aspirin, nonsteroidal anti‐inflammatory drug and paracetamol use with PSA‐detected prostate cancer: Findings from a large, population‐based, case–control study (the ProtecT study) , 2011, International journal of cancer.
[37] J. Potter,et al. Nonsteroidal Anti-Inflammatory Drugs and Prostate Cancer Risk in the VITamins And Lifestyle (VITAL) Cohort , 2010, Cancer Epidemiology, Biomarkers & Prevention.
[38] E. Franco,et al. Use of nonsteroidal anti‐inflammatory drugs and prostate cancer risk: A meta‐analysis , 2010, International journal of cancer.
[39] P. Nelson,et al. Use of aspirin and other nonsteroidal antiinflammatory medications in relation to prostate cancer risk. , 2010, American journal of epidemiology.
[40] Timo Ylikomi,et al. Effects of simvastatin, acetylsalicylic acid, and rosiglitazone on proliferation of normal and cancerous prostate epithelial Cells at therapeutic concentrations , 2009, The Prostate.
[41] M. Thun,et al. Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement. , 2009, The Lancet. Oncology.
[42] E. Klein,et al. Risk factors for prostate cancer , 2009, Nature Clinical Practice Urology.
[43] Leslie H. Sobin,et al. Comprar TNM Classification of Malignant Tumours, 7th Edition | C. Wittekind | 9781444332414 | Wiley , 2009 .
[44] U. Vogel,et al. Aspirin and other non-steroidal anti-inflammatory drugs and risk of colorectal cancer: A Danish cohort study , 2009, Cancer Causes & Control.
[45] Randall Harris,et al. Cancer chemoprevention by cyclooxygenase 2 (COX-2) blockade: results of case control studies. , 2007, Sub-cellular biochemistry.
[46] H. Sørensen,et al. Cancer risk among users of neuroleptic medication: a population-based cohort study , 2006, British Journal of Cancer.
[47] Michael J Thun,et al. A large cohort study of aspirin and other nonsteroidal anti-inflammatory drugs and prostate cancer incidence. , 2005, Journal of the National Cancer Institute.
[48] A. Sabichi,et al. COX-2 inhibitors and other nonsteroidal anti-inflammatory drugs in genitourinary cancer. , 2004, Seminars in oncology.
[49] L. G. García Rodríguez,et al. Inverse association between nonsteroidal anti-inflammatory drugs and prostate cancer. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[50] R. Hayes,et al. Cancer Causes & Control , 2004, Cancer Causes & Control.
[51] H. Sørensen,et al. Diabetes and outcome of community-acquired pneumococcal bacteremia: a 10-year population-based cohort study. , 2004, Diabetes care.
[52] J. Olsen,et al. A population-based cohort study of the risk of colorectal and other cancers among users of low-dose aspirin , 2003, British Journal of Cancer.
[53] R. Lancashire,et al. Effect of anti-inflammatory drugs on overall risk of common cancer: case-control study in general practice research database , 2000, BMJ : British Medical Journal.
[54] A. Norrish,et al. Non‐steroidal anti‐inflammatory drugs and prostate cancer progression , 1998, International journal of cancer.
[55] H. Storm,et al. The Danish Cancer Registry--history, content, quality and use. , 1997, Danish medical bulletin.
[56] L. Sobin,et al. TNM Classification of Malignant Tumours , 1987, UICC International Union Against Cancer.
[57] Sander Greenland,et al. Modern Epidemiology 3rd edition , 1986 .